QIAGEN and Eppendorf Form Alliance for Development and Marketing of Life Science Solutions
QIAGEN to Acquire Eppendorf's Nucleic Acid Sample Preparation Kit and PCR Reagent Business
QIAGEN N.V. and Eppendorf AG announced that they have formed a strategic alliance that includes co-development and co-marketing of complementary and optimized products. The alliance is intended to link two of the strongest brands and product lines in the industry to ensure the highest compatibility of their products targeting the research, applied testing and molecular diagnostics.
In addition QIAGEN has acquired Eppendorf's reagent business which includes the Eppendorf "5-Prime" nucleic acid sample preparation and PCR reagent product lines and related intellectual property. The acquired assets represent an attractive portfolio of preanalytical and nucleic acid amplification consumables as well as a very promising pipeline of proprietary technologies for nucleic acid handling, separation, purification and amplification. The assets add to QIAGEN's core strategic focus. Financial terms of the transaction were not disclosed.
Other news from the department business & finance
